Allena Pharmaceuticals (NASDAQ:ALNA) on Tuesday said it had rescheduled its special meeting to consider and approve a reverse stock split of its common shares.
ALNA stock has lost 16.5% to $0.18 in ...
Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments